[1] XIE T W, ZHAO Q F, FU C X, et al.Differentiation of triple-negative breast cancer from other subtypes through whole-tumor histogram analysis on multiparametric MR imaging[J]. Eur Radiol, 2019,29(5):2535-2544. [2] 张浩永,章宏欣. 乳腺癌手术前后EGFR和VEGF表达及意义[J].预防医学,2017, 29(7):744-747. [3] 高传芬,王玲,解欣欣,等. 三阴乳腺癌的超声特征分析[J].安徽医学,2016,37(8): 993-995. [4] MOON W K,HUANG Y S,LO C M,et al.Computer-aided diagnosis for distinguishing between triple-negative breast cancer and fibroadenomas based on ultrasound texture features[J]. Med Phys, 2015,42(6):3024-3035. [5] WANG P,YUE W S,LI W Y,et al.Systemicimmune-inflammation index and ultrasonographic classification of breast imaging-reporting and data system predict outcomes of triple-negative breast cancer[J]. Cancer Manag Res, 2019(11): 813-819. [6] KAOKU S, KONISHI E, YANAGISAWA A, et al.Ultrasound features of triple negative breast cancer[J]. Nihon Rinsho, 2012, 70(Suppl. 7): 317-321. [7] VANEL D.The American College of Radiology (ACR) Breast Imaging and Reporting Data System (BI-RADS):a step towards a universal radiological language?[J]. Eur J Radiol, 2007, 61(2):183. [8] HAMMOND M E, HAYES D F, DOWSETT M, et al.American society of clinical oncology/college of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer[J]. J Oncol Pract, 2010,6(4):195-197. [9] 中国医师协会超声医师分会. 中国浅表器官超声检查指南[M]. 北京:人民卫生出版社,2017. [10] 李丹,徐华军,陈文显,等.不同负压抽吸在甲状腺结节细针穿刺中的应用[J].浙江中西医结合杂志,2018,28(5):370-372. [11] 徐巧巧,吕萍,颜波儿. 乳腺癌患者术后生命质量及影响因素分析[J].预防医学,2017,29(9):906-908,913. [12] 李菲. 三阴性乳腺癌常规超声及声触诊组织成像定量剪切波弹性成像特征[D].济南:山东大学,2018. [13] LI Z Y, TIAN J W, WANG X W, et al.Differences in multi- modal ultrasound imaging between triple negative and non-triple negative breast cancer[J]. Ultrasound Med Biol, 2016,42(4):882-890. [14] 王艳,张年庆,彭德峰,等. 三阴乳腺癌的危险因素和临床病理特征分析[J]. 中华全科医学,2017,15(6):930-933. [15] 袁聪聪. 超声造影在三阴性乳腺癌化疗疗效评估中的实验研究[D]. 上海:上海交通大学,2017.